IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TARA M ABBONDANZA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1730355173
CMS profile
10738368
Location
ARCADIA, CA

General Payments · PY2021–2024

$3,483.01

  • Reported across 173 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$891.32

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nurse Practitioner CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $891.32 49

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $176.48 7
NOVARTIS PHARMACEUTICALS CORPORATION $132.88 15
Boehringer Ingelheim Pharmaceuticals, Inc. $129.22 6
PFIZER INC. $106.57 5
E.R. Squibb & Sons, L.L.C. $95.98 4
Lexicon Pharmaceuticals, Inc. $63.95 2
Bayer HealthCare Pharmaceuticals Inc. $55.58 3
Inspire Medical Systems, Inc. $54.08 3
Acerta Pharma LLC $35.17 2
Kiniksa Pharmaceuticals International, plc $27.36 1
Merck Sharp & Dohme Corporation $14.05 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $525.43 27
PY2022 $1,126.48 51
PY2023 $939.78 46
PY2024 $891.32 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.93 01/04/2024 Food and Beverage Undisputed 01/23/2026 1105712536 CMS
AstraZeneca Pharmaceuticals LP $16.24 06/12/2024 Food and Beverage Undisputed 01/23/2026 1104540502 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.88 01/31/2024 Food and Beverage Undisputed 01/23/2026 1086319276 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.71 02/21/2024 Food and Beverage Undisputed 01/23/2026 1086351416 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.99 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086352348 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.17 01/11/2024 Food and Beverage Undisputed 01/23/2026 1118131693 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.86 04/10/2024 Food and Beverage Undisputed 01/23/2026 1118131691 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.85 07/25/2024 Food and Beverage Undisputed 01/23/2026 1118131697 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.60 08/27/2024 Food and Beverage Undisputed 01/23/2026 1118131687 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.84 09/05/2024 Food and Beverage Undisputed 01/23/2026 1118131695 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.90 10/18/2024 Food and Beverage Undisputed 01/23/2026 1118131689 CMS
E.R. Squibb & Sons, L.L.C. $27.29 02/09/2024 Food and Beverage Undisputed 01/23/2026 1101349500 CMS
E.R. Squibb & Sons, L.L.C. $22.08 05/23/2024 Food and Beverage Undisputed 01/23/2026 1101349528 CMS
E.R. Squibb & Sons, L.L.C. $25.52 07/10/2024 Food and Beverage Undisputed 01/23/2026 1101349540 CMS
E.R. Squibb & Sons, L.L.C. $21.09 09/12/2024 Food and Beverage Undisputed 01/23/2026 1101349564 CMS
Inspire Medical Systems, Inc. $14.71 09/03/2024 Food and Beverage Undisputed 01/23/2026 1148130706 CMS
Inspire Medical Systems, Inc. $15.21 09/18/2024 Food and Beverage Undisputed 01/23/2026 1148130710 CMS
Inspire Medical Systems, Inc. $24.16 09/27/2024 Food and Beverage Undisputed 01/23/2026 1148130715 CMS
Janssen Pharmaceuticals, Inc $29.91 02/05/2024 Food and Beverage Undisputed 01/23/2026 1077918945 CMS
Janssen Pharmaceuticals, Inc $23.55 02/26/2024 Food and Beverage Undisputed 01/23/2026 1077918845 CMS
Janssen Pharmaceuticals, Inc $24.88 03/27/2024 Food and Beverage Undisputed 01/23/2026 1077918865 CMS
Janssen Pharmaceuticals, Inc $25.69 04/08/2024 Food and Beverage Undisputed 01/23/2026 1077918967 CMS
Janssen Pharmaceuticals, Inc $25.12 05/06/2024 Food and Beverage Undisputed 01/23/2026 1077918935 CMS
Janssen Pharmaceuticals, Inc $18.24 05/09/2024 Food and Beverage Undisputed 01/23/2026 1077918859 CMS
Janssen Pharmaceuticals, Inc $29.09 06/06/2024 Food and Beverage Undisputed 01/23/2026 1077918929 CMS
Kiniksa Pharmaceuticals International, plc $27.36 10/08/2024 Food and Beverage Undisputed 01/23/2026 1154884177 CMS
Lexicon Pharmaceuticals, Inc. $30.60 04/25/2024 Food and Beverage Undisputed 01/23/2026 1081731379 CMS
Lexicon Pharmaceuticals, Inc. $33.35 07/16/2024 Food and Beverage Undisputed 01/23/2026 1081731381 CMS
Merck Sharp & Dohme LLC $14.05 04/02/2024 Food and Beverage Undisputed 01/23/2026 1141866018 CMS
Novartis Pharmaceuticals Corporation $23.14 01/30/2024 Food and Beverage Undisputed 01/23/2026 1086721665 CMS
Novartis Pharmaceuticals Corporation $3.26 02/08/2024 Food and Beverage Undisputed 01/23/2026 1086721661 CMS
Novartis Pharmaceuticals Corporation $6.29 02/08/2024 Food and Beverage Undisputed 01/23/2026 1086721663 CMS
Novartis Pharmaceuticals Corporation $1.64 03/12/2024 Food and Beverage Undisputed 01/23/2026 1086721667 CMS
Novartis Pharmaceuticals Corporation $8.78 04/08/2024 Food and Beverage Undisputed 01/23/2026 1086721671 CMS
Novartis Pharmaceuticals Corporation $1.52 04/15/2024 Food and Beverage Undisputed 01/23/2026 1086721675 CMS
Novartis Pharmaceuticals Corporation $13.29 04/15/2024 Food and Beverage Undisputed 01/23/2026 1086721677 CMS
Novartis Pharmaceuticals Corporation $22.22 04/29/2024 Food and Beverage Undisputed 01/23/2026 1086721683 CMS
Novartis Pharmaceuticals Corporation $25.54 05/21/2024 Food and Beverage Undisputed 01/23/2026 1086721693 CMS
Novartis Pharmaceuticals Corporation $7.03 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086721689 CMS
Novartis Pharmaceuticals Corporation $11.49 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086721691 CMS
Novartis Pharmaceuticals Corporation $1.93 06/18/2024 Food and Beverage Undisputed 01/23/2026 1086721703 CMS
Novartis Pharmaceuticals Corporation $3.23 07/05/2024 Food and Beverage Undisputed 01/23/2026 1086721705 CMS
Novartis Pharmaceuticals Corporation $1.70 11/21/2024 Food and Beverage Undisputed 01/23/2026 1086721723 CMS
Novartis Pharmaceuticals Corporation $1.82 12/23/2024 Food and Beverage Undisputed 01/23/2026 1086721727 CMS
PFIZER INC. $23.40 03/12/2024 Food and Beverage Undisputed 01/23/2026 1131042870 CMS
PFIZER INC. $19.74 04/23/2024 Food and Beverage Undisputed 01/23/2026 1131398067 CMS
PFIZER INC. $25.33 05/28/2024 Food and Beverage Undisputed 01/23/2026 1131449185 CMS
PFIZER INC. $18.52 07/17/2024 Food and Beverage Undisputed 01/23/2026 1131754134 CMS
PFIZER INC. $19.58 08/28/2024 Food and Beverage Undisputed 01/23/2026 1131841708 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.